PHF20 was first identified as an antigen in glioblastoma patients and is highly expressed in different tumors, with potential roles in the development and progression of different cancers, such as glioma, adenocarcinomas, and lung cancer (25, 26, 27, 28). This evidence concerns the gene PHF20 and cancer.